US Supreme Court will not hear drug industry challenge to Arkansas contract pharmacy law
The U.S. Supreme Court on Monday declined to hear an appeal by the nation's leading drug industry group challenging an Arkansas law requiring pharmaceutical companies to offer discounts on drugs dispensed by third-party pharmacies that contract with hospitals and clinics serving low-income populations.
Supreme Court rejects drug industry challenge to Arkansas 340B law
The decision affirms a lower court's ruling that found no federal preemption of Arkansas' Act 1103, which restricts pharmaceutical manufacturers from limiting the ability of covered entities to use contract pharmacies for distributing discounted drugs under the 340B program, according to court documents obtained by Becker's.
B experts joined BlackDoctor.org in a lively and information conversation about 340B accountability and what can be done moving forward ...
The pharmaceutical industry is not lobbying senators to stop the confirmation of long-time critic Robert F. Kennedy Jr.
Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it doles out ...
We strongly support Dr. Farhan Bhatti's call for reform, while also emphasizing the need for transparency in the 340B Drug ...
The deal, as reported by The Australian Financial Review, would give the government a bigger say in the ultimate fate of the ...
In its complaint, BMS alleges that HHS' Health Resources and Services Administration (HRSA), which has responsibility for ...
AHA President and CEO Rick Pollack this week received the ASHP Award of Honor, which recognizes individuals outside the ...
Drugmakers have been urging for changes to the 340B Drug Pricing Program, which allows qualifying hospitals and clinics to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback